Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

ERK1 And ERK2 Activities Are Key To Ovarian Functions And Fertility
Two enzymes called extracellular signal-regulated kinases (ERK1 and ERK2) are critical factors in a pathway that induces ovulation, maturation of the mammalian egg (oocyte) and other activities key to ovarian function and female fertility, said a group of researchers at Baylor College of Medicine (BCM) in a report that appears today in the journal Science.

British Public Putting Their Eyesight At Risk
NEARLY two thirds of the British public are neglecting their eyesight, according to the results of a shock survey released today.
News of the day
Vystar(R) Corporation And Alatech Healthcare, LLC Announce FDA 510(k) Clearance For Exam Gloves Made With Vytex(R) NRL
Vystar Corporation and Alatech Healthcare, LLC announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the first exam gloves manufactured with Vytex® Natural Rubber Latex (NRL). Alatech plans to introduce exam gloves made with Vytex NRL in the near future.
Health Insurance

The Endocrine Society Responds To Recent Insulin Glargine (Lantus(R)) Study With Recommendations For Patients And Physicians

Five articles recently posted online in the medical journal Diabetologia studied the possible connection between the use of insulin glargine (Lantus®) and the development of cancer. While one of these studies suggested an increased risk of cancer, the other four did not come to the same conclusion. Taken together, the results of all these studies do not conclusively show that insulin glargine causes cancer or is otherwise harmful to a patient"s overall health. In terms of clinical practice, there does not appear to be sufficient evidence to recommend against the use of insulin glargine. The Society anticipates that as medical experts perform new studies, the potential risks and benefits of insulin glargine will become more clearly defined. To address concerns about the potential relationship between insulin glargine and cancer, the Society has issued two statements: one for patients and the other for physicians. In the statements, available online at http://www.endo-society.org/advocacy/policy/index.cfm, the Society provides a summary of the studies published in Diabetologia and offers recommendations regarding treatment of diabetic patients. The Society recommends that patients continue with their insulin regimen and discuss with their physicians the reasons why a particular insulin treatment was prescribed. In addition, patients with diabetes, like all other individuals, should make sure that they follow recommended procedures for screening and early detection of cancer, such as periodic mammography and colonoscopy. The Society recommends that physicians continue to individualize their therapy based on a patient"s situation and encourage their patients to follow current recommendations for screening tests for cancer and avoid dangerous habits, such as smoking. The Endocrine Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009